ArticleCase reports in oncology
Noncutaneous Visceral Kaposi Sarcoma of the Stomach and Liver: A Case Report.
Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Kaposi sarcoma (KS) is an angioproliferative neoplasm caused by human herpes virus-8, most commonly affecting immunocompromised individuals, particularly those with HIV/AIDS. While KS typically presents with violaceous cutaneous lesions, visceral involvement, especially in the gastrointestinal and hepatic systems, is rare and often asymptomatic. Case Presentation: We describe an uncommon presentation of AIDS-related KS involving the liver, stomach, and lungs in a 25-year-old male with poorly controlled HIV. Despite the absence of cutaneous manifestations, KS was diagnosed with a high index of suspicion, and appropriate treatment was initiated with antiretroviral therapy along with plans to initiate chemotherapy in the outpatient setting. Conclusion: This case highlights the importance of considering visceral KS in HIV/AIDS patients even in the absence of skin lesions, as early diagnosis and intervention can improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.